Connect Biopharma Holdings (CNTB) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Connect Biopharma Holdings Limited has announced the transition of two key figures, Dr. Zheng Wei and Dr. Wubin Pan, to non-executive roles within the company. Dr. Zheng Wei will serve as Senior Advisor and Dr. Wubin Pan as General Manager of Greater China Operations, each with a respective base salary and continued benefits until the end of 2024 or until their employment termination. These changes are now part of the company’s official filings with the Securities and Exchange Commission.
For further insights into CNTB stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges